TCDAQ — Tricida Share News
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
Brief: Tricida Inc Receives Notice Of Delisting From Nasdaq
Brief: Tricida Inc Filed Voluntary Petition For Relief Under Chapter 11
Brief: Tricida - On December 19, 2022, Tricida Received An Additional Letter From Patheon Referencing The Purported Termination Notice From December 7, 2022
Brief: Tricida Inc - On December 6, Received Notice From Nasdaq That Co Is Not Been In Compliance With Minimum Bid Price Requirement - Filing
Tricida Inc reports results for the quarter ended in September - Earnings Summary
Brief: Tricida Announces Third Quarter 2022 Financial Results
Tricida Inc expected to post a loss of 54 cents a share - Earnings Preview
Brief: Tricida Provides Strategic Update
U.S. RESEARCH ROUNDUP-Arista Networks, Planet Fitness, Tricida
U.S. STOCKS ON THE MOVE-Starbucks, Tesla, Wynn Resorts
Tricida hits record low as kidney disease drug fails in study
U.S. STOCKS ON THE MOVE-TransDigm, Vaxcyte, Tricida
Brief: Tricida Reports Topline Results From The Valor-Ckd Phase 3 Trial Of Veverimer
U.S. STOCKS ON THE MOVE -Orion,Tesla,Amazon
Tricida slumps as kidney disease drug fails in late-stage study
Brief: Tricida Announces $125 Mln Debt Facility With Hercules Capital
Brief: Tricida Announces The Selection Of The Valor-CKD Trial For An Oral Presentation In The High-Impact Clinical Trials Session At ASN Kidney Week 2022
Tricida Inc reports results for the quarter ended in June - Earnings Summary
Brief: Tricida Reports Qtrly Loss Per Share $0.67